The combination the antibiotic ceftazidime plus the compound NXL104 is active against bacterial pathogens containing genes that confer resistance to multiple carbapenems, according to new research.
The combination the antibiotic ceftazidime plus the compound NXL104 is active against bacterial pathogens containing genes that confer resistance to multiple carbapenems, according to new research.